Related Experiment Video
Updated: May 11, 2026

Continuous Fluorescence-Based Endonuclease-Coupled DNA Methylation Assay to Screen for DNA Methyltransferase Inhibitors
Published on: August 5, 2022
Endogenous APOBEC3A DNA cytosine deaminase is cytoplasmic and nongenotoxic
Allison M Land1, Emily K Law, Michael A Carpenter
1Department of Biochemistry, Molecular Biology and Biophysics, Institute for Molecular Virology, Masonic Cancer Center, and Center for Genome Engineering, University of Minnesota, Minneapolis, Minnesota 55455, USA.
Abstract:
APOBEC3A (A3A) is a myeloid lineage-specific DNA cytosine deaminase with a role in innate immunity to foreign DNA. Previous studies have shown that heterologously expressed A3A is genotoxic, suggesting that monocytes may have a mechanism to regulate this enzyme. Indeed, we observed no significant cytotoxicity when interferon was used to induce the expression of endogenous A3A in CD14(+)-enriched primary cells or the monocytic cell line THP-1. In contrast, doxycycline-induced A3A in HEK293 cells caused major cytotoxicity at protein levels lower than those observed when CD14(+) cells were stimulated with interferon. Immunofluorescent microscopy of interferon-stimulated CD14(+) and THP-1 cells revealed that endogenous A3A is cytoplasmic, in stark contrast to stably or transiently transfected A3A, which has a cell-wide localization. A3A constructs engineered to be cytoplasmic are also nontoxic in HEK293 cells. These data combine to suggest that monocytic cells use a cytoplasmic retention mechanism to control A3A and avert genotoxicity during innate immune responses.
Insights
Monocytes control the DNA-editing enzyme APOBEC3A (A3A) by keeping it in the cytoplasm, preventing its toxic effects during immune responses. This mechanism protects cells from A3A-induced genotoxicity.
Area of Science:
- Molecular Biology
- Immunology
- Genetics
Background:
- APOBEC3A (A3A) is a DNA cytosine deaminase involved in innate immunity.
- Exogenously expressed A3A is genotoxic, implying regulatory mechanisms in monocytes.
Purpose of the Study:
- Investigate how monocytic cells regulate endogenous A3A expression and prevent cytotoxicity.
- Determine the cellular localization of endogenous A3A and its correlation with toxicity.
Main Methods:
- Induction of endogenous A3A expression using interferon in CD14+ cells and THP-1.
- Induction of A3A expression using doxycycline in HEK293 cells.
- Immunofluorescent microscopy to assess A3A cellular localization.
Main Results:
- Endogenous A3A induced by interferon in monocytic cells showed no significant cytotoxicity.
- Doxycycline-induced A3A in HEK293 cells caused significant cytotoxicity at lower protein levels.
- Interferon-stimulated endogenous A3A localized to the cytoplasm in monocytic cells, unlike transfected A3A.
Conclusions:
- Monocytic cells employ a cytoplasmic retention mechanism to control A3A.
- This localization mechanism prevents A3A-mediated genotoxicity during innate immune responses.
Related Concept Videos
RNA Editing
Allosteric Proteins-ATCase
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis pathway,...
Biosynthesis of Nucleic Acids
Base Excision Repair
The first step of...
Overview of DNA Repair
Chemically...
The Intrinsic Apoptotic Pathway

